Eli Lilly and Company

Eli Lilly and Company (www.lilly.com) is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.

• Infrastructura de irigatii a Romaniei - 24 noiembrie 2025
• Start pentru Fidelis in noiembrie - 07 noiembrie 2025
• Scad inmatricularile de autoturisme noi - 26 septembrie 2025
• Criza acuta de forta de munca - 27 august 2025
• Industria, in scadere substantiala - 08 august 2025
• Inflatia anuala si dobanda de politica monetara in Romania - 18 iunie 2025
• Populatia Romaniei, in scadere - 29 aprilie 2025
• Romania, tara cu cel mai mare deficit bugetar din UE in 2024 - 24 aprilie 2025
• Autorizatiile de construire in februarie 2025 - 01 aprilie 2025
• Deficitul comercial, in crestere - 11 decembrie 2024